Speakers
Melinda Solomon, MD, FRCPC
The Hospital for Sick Children (SickKids), Toronto, ON

Diana Elizabeth Tullis, MD, FRCPC
Unity Health, Toronto, ON

Moderator
Mark Chilvers, MRCPCH, MD, BSc, MBChB
BC Children’s Hospital, Vancouver, BC

Session Description

The 2022 Annual Data Report for the Canadian Cystic Fibrosis Registry has shown a substantial increase in the median age of survival for Canadians living with cystic fibrosis (CF), rising to 60 years in 2022. This can be attributed to quality of CF care, research, and treatments, including expanding access to CFTR modulators. With this increasing lifespan, many questions arise around implications for patients with CF and how clinical care can evolve accordingly. This program would provide an update on CF clinical care in Canada and use interactive patient cases to explore unique considerations for both pediatric and adult audiences, from nutrition recommendations/evolving treatment plans to family planning/future planning/cancer risk/menopause (key topics of interest can be found in the included needs assessment). The proposed speakers will bring both adult and pediatric patient perspectives to the symposium, allowing for a balanced look at unique cross-country challenges for each age group, including optimizing the transition from pediatric to adult care. While focused on CF, the potential role of local respiratory care teams in the evolving care of patients with CF can be featured, making this symposium of interest to a broad respiratory audience.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • Describe the evolution of the cystic fibrosis (CF) treatment paradigm in Canada and its impact on clinical management and burden of care, including increased survival
  • Identify important new aging considerations for both pediatric and adult patients and apply available management strategies
  • Incorporate strategies to optimize the transition to adulthood in patients with CF

CanMEDS Roles: Collaborator, Communicator, Health Advocate, Medical Expert, Scholar

This session is co-developed by the CTS and Vertex and is planned to achieve scientific integrity, objectivity and balance.